Skip to main content
. 2020 Sep 29;11:568636. doi: 10.3389/fimmu.2020.568636

Figure 6.

Figure 6

Effect of Lacticaseibacillus rhamnosus CRL1505 on broncho-alveolar lavages (BAL) leucocytes variations and CXCL1 and IL-17 levels in response to Respiratory Syncytial Virus (RSV) infection. Infant mice were orally treated with L. rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 (108 cell/mouse/day) during five consecutive days. One day after the last lactobacilli administration, mice were challenged with RSV. The numbers of BAL leucocytes, neutrophils, lymphocytes, and macrophages/monocytes were evaluated before (basal) and 2 days after the RSV infection. The levels of BAL CXCL1 and IL-17 were measured 2 days after RSV challenge. The results represent data from three independent experiments. Asterisks indicate significant differences when compared to the control group. *P < 0.05.